カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の腫瘍用栄養市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Tumor Nutrition Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19679）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19679
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の腫瘍用栄養市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

腫瘍用栄養市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の腫瘍用栄養の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

腫瘍用栄養市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・胃がん用栄養学、膵臓がん用栄養学、その他

用途別セグメントは次のように区分されます。
・早期がん患者、進行がん患者

世界の腫瘍用栄養市場の主要な市場プレーヤーは以下のとおりです。
・Danone、Nestle、Abbott、Fresenius Kabi、Mead Johnson Company、Meiji Holdings、Hormel Foods Corporation、Global Health Products、Victus

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、腫瘍用栄養製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な腫瘍用栄養メーカーの企業概要、2019年～2022年までの腫瘍用栄養の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な腫瘍用栄養メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別腫瘍用栄養の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの腫瘍用栄養の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腫瘍用栄養市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および腫瘍用栄養の産業チェーンを掲載しています。
・第13、14、15章では、腫瘍用栄養の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 腫瘍用栄養の概要
- 種類別分析（2017年vs2021年vs2028年）：胃がん用栄養学、膵臓がん用栄養学、その他
- 用途別分析（2017年vs2021年vs2028年）：早期がん患者、進行がん患者
- 世界の腫瘍用栄養市場規模・予測
- 世界の腫瘍用栄養生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Danone、Nestle、Abbott、Fresenius Kabi、Mead Johnson Company、Meiji Holdings、Hormel Foods Corporation、Global Health Products、Victus
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：胃がん用栄養学、膵臓がん用栄養学、その他
・用途別分析2017年-2028年：早期がん患者、進行がん患者
・腫瘍用栄養の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・腫瘍用栄養のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・腫瘍用栄養のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・腫瘍用栄養の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・腫瘍用栄養の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tumor Nutrition market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tumor Nutrition market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Early Cancer Patients accounting for % of the Tumor Nutrition global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nutrition for Stomach Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tumor Nutrition include Danone, Nestle, Abbott, Fresenius Kabi, and Mead Johnson Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tumor Nutrition market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Nutrition for Stomach Cancer
Nutrition for Pancreatic Cancer
Other
Market segment by Application can be divided into
Early Cancer Patients
Advanced Cancer Patients
The key market players for global Tumor Nutrition market are listed below:
Danone
Nestle
Abbott
Fresenius Kabi
Mead Johnson Company
Meiji Holdings
Hormel Foods Corporation
Global Health Products
Victus
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Nutrition product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tumor Nutrition, with price, sales, revenue and global market share of Tumor Nutrition from 2019 to 2022.
Chapter 3, the Tumor Nutrition competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Nutrition breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tumor Nutrition market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor Nutrition.
Chapter 13, 14, and 15, to describe Tumor Nutrition sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Tumor Nutrition Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tumor Nutrition Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Nutrition for Stomach Cancer
1.2.3 Nutrition for Pancreatic Cancer
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Tumor Nutrition Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Early Cancer Patients
1.3.3 Advanced Cancer Patients
1.4 Global Tumor Nutrition Market Size & Forecast
1.4.1 Global Tumor Nutrition Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tumor Nutrition Sales in Volume (2017-2028)
1.4.3 Global Tumor Nutrition Price (2017-2028)
1.5 Global Tumor Nutrition Production Capacity Analysis
1.5.1 Global Tumor Nutrition Total Production Capacity (2017-2028)
1.5.2 Global Tumor Nutrition Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tumor Nutrition Market Drivers
1.6.2 Tumor Nutrition Market Restraints
1.6.3 Tumor Nutrition Trends Analysis
2 Manufacturers Profiles
2.1 Danone
2.1.1 Danone Details
2.1.2 Danone Major Business
2.1.3 Danone Tumor Nutrition Product and Services
2.1.4 Danone Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Nestle
2.2.1 Nestle Details
2.2.2 Nestle Major Business
2.2.3 Nestle Tumor Nutrition Product and Services
2.2.4 Nestle Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Tumor Nutrition Product and Services
2.3.4 Abbott Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Tumor Nutrition Product and Services
2.4.4 Fresenius Kabi Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mead Johnson Company
2.5.1 Mead Johnson Company Details
2.5.2 Mead Johnson Company Major Business
2.5.3 Mead Johnson Company Tumor Nutrition Product and Services
2.5.4 Mead Johnson Company Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Meiji Holdings
2.6.1 Meiji Holdings Details
2.6.2 Meiji Holdings Major Business
2.6.3 Meiji Holdings Tumor Nutrition Product and Services
2.6.4 Meiji Holdings Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hormel Foods Corporation
2.7.1 Hormel Foods Corporation Details
2.7.2 Hormel Foods Corporation Major Business
2.7.3 Hormel Foods Corporation Tumor Nutrition Product and Services
2.7.4 Hormel Foods Corporation Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Global Health Products
2.8.1 Global Health Products Details
2.8.2 Global Health Products Major Business
2.8.3 Global Health Products Tumor Nutrition Product and Services
2.8.4 Global Health Products Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Victus
2.9.1 Victus Details
2.9.2 Victus Major Business
2.9.3 Victus Tumor Nutrition Product and Services
2.9.4 Victus Tumor Nutrition Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tumor Nutrition Breakdown Data by Manufacturer
3.1 Global Tumor Nutrition Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tumor Nutrition Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tumor Nutrition
3.4 Market Concentration Rate
3.4.1 Top 3 Tumor Nutrition Manufacturer Market Share in 2021
3.4.2 Top 6 Tumor Nutrition Manufacturer Market Share in 2021
3.5 Global Tumor Nutrition Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tumor Nutrition Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tumor Nutrition Market Size by Region
4.1.1 Global Tumor Nutrition Sales in Volume by Region (2017-2028)
4.1.2 Global Tumor Nutrition Revenue by Region (2017-2028)
4.2 North America Tumor Nutrition Revenue (2017-2028)
4.3 Europe Tumor Nutrition Revenue (2017-2028)
4.4 Asia-Pacific Tumor Nutrition Revenue (2017-2028)
4.5 South America Tumor Nutrition Revenue (2017-2028)
4.6 Middle East and Africa Tumor Nutrition Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tumor Nutrition Sales in Volume by Type (2017-2028)
5.2 Global Tumor Nutrition Revenue by Type (2017-2028)
5.3 Global Tumor Nutrition Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tumor Nutrition Sales in Volume by Application (2017-2028)
6.2 Global Tumor Nutrition Revenue by Application (2017-2028)
6.3 Global Tumor Nutrition Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tumor Nutrition Sales by Type (2017-2028)
7.2 North America Tumor Nutrition Sales by Application (2017-2028)
7.3 North America Tumor Nutrition Market Size by Country
7.3.1 North America Tumor Nutrition Sales in Volume by Country (2017-2028)
7.3.2 North America Tumor Nutrition Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tumor Nutrition Sales by Type (2017-2028)
8.2 Europe Tumor Nutrition Sales by Application (2017-2028)
8.3 Europe Tumor Nutrition Market Size by Country
8.3.1 Europe Tumor Nutrition Sales in Volume by Country (2017-2028)
8.3.2 Europe Tumor Nutrition Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tumor Nutrition Sales by Type (2017-2028)
9.2 Asia-Pacific Tumor Nutrition Sales by Application (2017-2028)
9.3 Asia-Pacific Tumor Nutrition Market Size by Region
9.3.1 Asia-Pacific Tumor Nutrition Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tumor Nutrition Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tumor Nutrition Sales by Type (2017-2028)
10.2 South America Tumor Nutrition Sales by Application (2017-2028)
10.3 South America Tumor Nutrition Market Size by Country
10.3.1 South America Tumor Nutrition Sales in Volume by Country (2017-2028)
10.3.2 South America Tumor Nutrition Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tumor Nutrition Sales by Type (2017-2028)
11.2 Middle East & Africa Tumor Nutrition Sales by Application (2017-2028)
11.3 Middle East & Africa Tumor Nutrition Market Size by Country
11.3.1 Middle East & Africa Tumor Nutrition Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tumor Nutrition Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tumor Nutrition and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tumor Nutrition
12.3 Tumor Nutrition Production Process
12.4 Tumor Nutrition Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tumor Nutrition Typical Distributors
13.3 Tumor Nutrition Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Tumor Nutrition Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tumor Nutrition Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Danone Basic Information, Manufacturing Base and Competitors
Table 4. Danone Major Business
Table 5. Danone Tumor Nutrition Product and Services
Table 6. Danone Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Nestle Basic Information, Manufacturing Base and Competitors
Table 8. Nestle Major Business
Table 9. Nestle Tumor Nutrition Product and Services
Table 10. Nestle Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abbott Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Major Business
Table 13. Abbott Tumor Nutrition Product and Services
Table 14. Abbott Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 16. Fresenius Kabi Major Business
Table 17. Fresenius Kabi Tumor Nutrition Product and Services
Table 18. Fresenius Kabi Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mead Johnson Company Basic Information, Manufacturing Base and Competitors
Table 20. Mead Johnson Company Major Business
Table 21. Mead Johnson Company Tumor Nutrition Product and Services
Table 22. Mead Johnson Company Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Meiji Holdings Basic Information, Manufacturing Base and Competitors
Table 24. Meiji Holdings Major Business
Table 25. Meiji Holdings Tumor Nutrition Product and Services
Table 26. Meiji Holdings Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hormel Foods Corporation Basic Information, Manufacturing Base and Competitors
Table 28. Hormel Foods Corporation Major Business
Table 29. Hormel Foods Corporation Tumor Nutrition Product and Services
Table 30. Hormel Foods Corporation Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Health Products Basic Information, Manufacturing Base and Competitors
Table 32. Global Health Products Major Business
Table 33. Global Health Products Tumor Nutrition Product and Services
Table 34. Global Health Products Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Victus Basic Information, Manufacturing Base and Competitors
Table 36. Victus Major Business
Table 37. Victus Tumor Nutrition Product and Services
Table 38. Victus Tumor Nutrition Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Tumor Nutrition Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 40. Global Tumor Nutrition Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Tumor Nutrition, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Tumor Nutrition Production Capacity by Company, (MT): 2020 VS 2021
Table 43. Head Office and Tumor Nutrition Production Site of Key Manufacturer
Table 44. Tumor Nutrition New Entrant and Capacity Expansion Plans
Table 45. Tumor Nutrition Mergers & Acquisitions in the Past Five Years
Table 46. Global Tumor Nutrition Sales by Region (2017-2022) & (MT)
Table 47. Global Tumor Nutrition Sales by Region (2023-2028) & (MT)
Table 48. Global Tumor Nutrition Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Tumor Nutrition Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 51. Global Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 52. Global Tumor Nutrition Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Tumor Nutrition Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Tumor Nutrition Price by Type (2017-2022) & (USD/MT)
Table 55. Global Tumor Nutrition Price by Type (2023-2028) & (USD/MT)
Table 56. Global Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 57. Global Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 58. Global Tumor Nutrition Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Tumor Nutrition Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Tumor Nutrition Price by Application (2017-2022) & (USD/MT)
Table 61. Global Tumor Nutrition Price by Application (2023-2028) & (USD/MT)
Table 62. North America Tumor Nutrition Sales by Country (2017-2022) & (MT)
Table 63. North America Tumor Nutrition Sales by Country (2023-2028) & (MT)
Table 64. North America Tumor Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Tumor Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 67. North America Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 68. North America Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 69. North America Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 70. Europe Tumor Nutrition Sales by Country (2017-2022) & (MT)
Table 71. Europe Tumor Nutrition Sales by Country (2023-2028) & (MT)
Table 72. Europe Tumor Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Tumor Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 75. Europe Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 76. Europe Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 77. Europe Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 78. Asia-Pacific Tumor Nutrition Sales by Region (2017-2022) & (MT)
Table 79. Asia-Pacific Tumor Nutrition Sales by Region (2023-2028) & (MT)
Table 80. Asia-Pacific Tumor Nutrition Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Tumor Nutrition Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 83. Asia-Pacific Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 84. Asia-Pacific Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 85. Asia-Pacific Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 86. South America Tumor Nutrition Sales by Country (2017-2022) & (MT)
Table 87. South America Tumor Nutrition Sales by Country (2023-2028) & (MT)
Table 88. South America Tumor Nutrition Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Tumor Nutrition Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 91. South America Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 92. South America Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 93. South America Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 94. Middle East & Africa Tumor Nutrition Sales by Region (2017-2022) & (MT)
Table 95. Middle East & Africa Tumor Nutrition Sales by Region (2023-2028) & (MT)
Table 96. Middle East & Africa Tumor Nutrition Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Tumor Nutrition Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Tumor Nutrition Sales by Type (2017-2022) & (MT)
Table 99. Middle East & Africa Tumor Nutrition Sales by Type (2023-2028) & (MT)
Table 100. Middle East & Africa Tumor Nutrition Sales by Application (2017-2022) & (MT)
Table 101. Middle East & Africa Tumor Nutrition Sales by Application (2023-2028) & (MT)
Table 102. Tumor Nutrition Raw Material
Table 103. Key Manufacturers of Tumor Nutrition Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Tumor Nutrition Typical Distributors
Table 107. Tumor Nutrition Typical Customers
List of Figures
Figure 1. Tumor Nutrition Picture
Figure 2. Global Tumor Nutrition Revenue Market Share by Type in 2021
Figure 3. Nutrition for Stomach Cancer
Figure 4. Nutrition for Pancreatic Cancer
Figure 5. Other
Figure 6. Global Tumor Nutrition Revenue Market Share by Application in 2021
Figure 7. Early Cancer Patients
Figure 8. Advanced Cancer Patients
Figure 9. Global Tumor Nutrition Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Tumor Nutrition Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Tumor Nutrition Sales (2017-2028) & (MT)
Figure 12. Global Tumor Nutrition Price (2017-2028) & (USD/MT)
Figure 13. Global Tumor Nutrition Production Capacity (2017-2028) & (MT)
Figure 14. Global Tumor Nutrition Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Tumor Nutrition Market Drivers
Figure 16. Tumor Nutrition Market Restraints
Figure 17. Tumor Nutrition Market Trends
Figure 18. Global Tumor Nutrition Sales Market Share by Manufacturer in 2021
Figure 19. Global Tumor Nutrition Revenue Market Share by Manufacturer in 2021
Figure 20. Tumor Nutrition Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Tumor Nutrition Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Tumor Nutrition Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Tumor Nutrition Sales Market Share by Region (2017-2028)
Figure 24. Global Tumor Nutrition Revenue Market Share by Region (2017-2028)
Figure 25. North America Tumor Nutrition Revenue (2017-2028) & (USD Million)
Figure 26. Europe Tumor Nutrition Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Tumor Nutrition Revenue (2017-2028) & (USD Million)
Figure 28. South America Tumor Nutrition Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Tumor Nutrition Revenue (2017-2028) & (USD Million)
Figure 30. Global Tumor Nutrition Sales Market Share by Type (2017-2028)
Figure 31. Global Tumor Nutrition Revenue Market Share by Type (2017-2028)
Figure 32. Global Tumor Nutrition Price by Type (2017-2028) & (USD/MT)
Figure 33. Global Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 34. Global Tumor Nutrition Revenue Market Share by Application (2017-2028)
Figure 35. Global Tumor Nutrition Price by Application (2017-2028) & (USD/MT)
Figure 36. North America Tumor Nutrition Sales Market Share by Type (2017-2028)
Figure 37. North America Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 38. North America Tumor Nutrition Sales Market Share by Country (2017-2028)
Figure 39. North America Tumor Nutrition Revenue Market Share by Country (2017-2028)
Figure 40. United States Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Tumor Nutrition Sales Market Share by Type (2017-2028)
Figure 44. Europe Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 45. Europe Tumor Nutrition Sales Market Share by Country (2017-2028)
Figure 46. Europe Tumor Nutrition Revenue Market Share by Country (2017-2028)
Figure 47. Germany Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Tumor Nutrition Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Tumor Nutrition Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Tumor Nutrition Revenue Market Share by Region (2017-2028)
Figure 56. China Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Tumor Nutrition Sales Market Share by Type (2017-2028)
Figure 63. South America Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 64. South America Tumor Nutrition Sales Market Share by Country (2017-2028)
Figure 65. South America Tumor Nutrition Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Tumor Nutrition Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Tumor Nutrition Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Tumor Nutrition Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Tumor Nutrition Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Tumor Nutrition Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Tumor Nutrition in 2021
Figure 77. Manufacturing Process Analysis of Tumor Nutrition
Figure 78. Tumor Nutrition Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • インターベンショナル腫瘍アブレーションの世界市場2023年：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション
  • 腫瘍細胞分離キットの世界市場2023年：乳癌腫瘍細胞分離、黒色腫腫瘍細胞分離、卵巣癌腫瘍細胞分離、その他
  • 腫瘍NGS検出のグローバル市場展望 2023年-2029年：医療機器、消耗品
  • 細胞性腫瘍抗原p53のグローバル市場展望 2023年-2029年：COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他
  • 世界の犬用栄養補助食品市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19679 )"世界の腫瘍用栄養市場2022年：市場規模予測（～2028年）" (英文：Global Tumor Nutrition Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。